| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6825774 | Schizophrenia Research | 2013 | 6 Pages |
Abstract
These data support the hypothesis of a restrictive epigenome in schizophrenia, and may associate with symptoms that are notoriously treatment resistant. The histone methyltransferases measured here are potential future therapeutic targets for small molecule pharmacology, and better patient prognosis.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Kayla A. Chase, David P. Gavin, Alessandro Guidotti, Rajiv P. Sharma,